These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1736749)

  • 21. Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta.
    Mutsaers SE; Harrison NK; McAnulty RJ; Liao JY; Laurent GJ; Musk AW
    J Pathol; 1998 Jun; 185(2):199-203. PubMed ID: 9713348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis.
    Hoffman GS; Sechler JM; Gallin JI; Shelhamer JH; Suffredini A; Ognibene FP; Baltaro RJ; Fleisher TA; Leavitt RY; Travis WD
    Am Rev Respir Dis; 1991 Feb; 143(2):401-7. PubMed ID: 1990960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytoimmunological changes in the bronchoalveolar lavage in asbestos exposure patients].
    Gil K
    Folia Med Cracov; 2006; 47(1-4):21-36. PubMed ID: 18038610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between neutrophil concentration in bronchoalveolar lavage fluid and recent losses in diffusing capacity in men formerly exposed to asbestos.
    Cullen MR; Merrill WW
    Chest; 1992 Sep; 102(3):682-7. PubMed ID: 1516387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivity of bronchoalveolar space cells in lung asbestosis.
    Czarnobilska E; Kopiński P; Pituch-Noworolska A; Chłap Z
    Patol Pol; 1992; 43(1):19-23. PubMed ID: 1296169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced diffusing capacity as an isolated finding in asbestos- and silica-exposed workers.
    Garcia JG; Griffith DE; Williams JS; Blevins WJ; Kronenberg RS
    Chest; 1990 Jul; 98(1):105-11. PubMed ID: 2163299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma.
    Sebastien P; Armstrong B; Monchaux G; Bignon J
    Am Rev Respir Dis; 1988 Jan; 137(1):75-8. PubMed ID: 3337472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asbestos fibers in bronchoalveolar lavage and lung tissue of former asbestos workers.
    Teschler H; Friedrichs KH; Hoheisel GB; Wick G; Soltner U; Thompson AB; Konietzko N; Costabel U
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):641-5. PubMed ID: 8118631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage.
    Maestrelli P; Saetta M; Di Stefano A; Calcagni PG; Turato G; Ruggieri MP; Roggeri A; Mapp CE; Fabbri LM
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1926-31. PubMed ID: 8520757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interleukin-1 beta production by alveolar macrophages in cases of asbestos exposure].
    Tokuyama T; Yoneda T; Tamura M; Tsukaguchi K; Yoshikawa M; Tou R; Narita N; Kasuga H; Miyazaki R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):193-8. PubMed ID: 8515598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular and molecular basis of the asbestos-related diseases.
    Rom WN; Travis WD; Brody AR
    Am Rev Respir Dis; 1991 Feb; 143(2):408-22. PubMed ID: 1990961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asbestos exposure results in increased lung procoagulant activity in vivo and in vitro.
    Callahan KS; Griffith DE; Garcia JG
    Chest; 1990 Jul; 98(1):112-9. PubMed ID: 2361375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchoalveolar lavage analysis, gallium-67 lung scanning and soluble interleukin-2 receptor levels in asbestos exposure.
    Delclos GL; Flitcraft DG; Brousseau KP; Windsor NT; Nelson DL; Wilson RK; Lawrence EC
    Environ Res; 1989 Apr; 48(2):164-78. PubMed ID: 2538325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pleural fibrosis in asbestosis and ventilatory function: a study of 50 cases].
    Tomasini M; Rivolta G; Calori A; Nicoli E; Ferretti G; Chiappino G
    Med Lav; 1992; 83(2):178-85. PubMed ID: 1630406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bronchoalveolar lavage in diagnosis of chronic obstructive pulmonary disease].
    Shimura S
    Nihon Rinsho; 1999 Sep; 57(9):2005-11. PubMed ID: 10497398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Markers of fibrogenesis in bronchoalveolar lavage and in serum of workers exposed to asbestos].
    Salberini I; Rivolta G; Todaro A; Forni A; Annoni G; Chiappino G
    Med Lav; 1991; 82(3):238-47. PubMed ID: 1795668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid.
    Schwartz DA; Galvin JR; Burmeister LF; Merchant RK; Dayton CS; Merchant JA; Hunninghake GW
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):684-8. PubMed ID: 1892311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical correlation of asbestos bodies in BAL fluid.
    Vathesatogkit P; Harkin TJ; Addrizzo-Harris DJ; Bodkin M; Crane M; Rom WN
    Chest; 2004 Sep; 126(3):966-71. PubMed ID: 15364780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking affects eotaxin levels in asthma patients.
    Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
    J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.